Information:
Fel:
ID
34306
Beskrivning
Vitamin D Supplementation for Treatment of Heart Failure; ODM derived from: https://clinicaltrials.gov/show/NCT01230307
Länk
https://clinicaltrials.gov/show/NCT01230307
Nyckelord
Versioner (1)
- 2019-01-16 2019-01-16 -
Rättsinnehavare
GSK group of companies
Uppladdad den
16 januari 2019
DOI
För en begäran logga in.
Licens
Creative Commons BY-NC 3.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Heart Failure NCT01230307
Eligibility Heart Failure NCT01230307
- StudyEvent: Eligibility
Similar models
Eligibility Heart Failure NCT01230307
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
ID.1
Item
hf patients with lv systolic dysfunction of ischemic or non-ischemic origin and an lvef <40% using nuclear ventriculography or echocardiography within the last 6 months.
boolean
ID.2
Item
attempts should have been made at optimizing medical therapy and the participant should be stable on these medications for at least 3 months.
boolean
ID.3
Item
patients with a 25(oh)d level between 10-25 ng/ml
boolean
ID.4
Item
inability to give informed consent
boolean
ID.5
Item
patients with sarcoidosis or other granulomatous disease that can alter vitamin d metabolism
boolean
ID.6
Item
patients with primary valvular hf, hypertrophic cardiomyopathy, and drug-induced hf
boolean
ID.7
Item
renal dysfunction defined as serum creatinine > 2.5 mg/dl
boolean
ID.8
Item
pregnant women
boolean
ID.9
Item
patients <18 years of age
boolean
ID.10
Item
patients on vitamin d supplementation
boolean